Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ACACB "ACC2, ACCB, HACC275" ENSG00000076555 "Acetyl-CoA carboxylase beta" O00763 12 109116595-109268226 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Allosteric enzyme, Ligase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 159.9;Peritubular cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.5" "Cell line enriched" "Detected in many" 18 "ASC diff: 73.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006554 Enhanced "Intracellular and membrane" NA NA "HPA006554: AB_1844495" "unprognostic (2.24e-1)" "unprognostic (4.66e-1)" "unprognostic (3.97e-2)" "unprognostic (4.54e-6)" "unprognostic (2.82e-1)" "unprognostic (1.59e-2)" "unprognostic (8.62e-3)" "unprognostic (5.81e-2)" "unprognostic (2.86e-1)" "unprognostic (1.63e-2)" "prognostic favorable (1.93e-4)" "unprognostic (6.63e-2)" "prognostic favorable (1.15e-5)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.21e-3)" "unprognostic (2.58e-2)" 104.5 8.2 4.3 10.6 4.0 1.6 67.4 3.3 3.5 3.5 19.3 3.2 6.2 3.8 4.6 4.3 4.9 3.9 10.5 12.1 4.5 2.0 5.4 42.0 3.1 4.0 6.4 2.7 6.8 8.5 8.9 7.1 1.3 3.7 3.6 3.9 4.0 5.8 9.0 154.2 2.8 4.8 7.5 6.5 2.5 5.6 1.6 4.9 0.4 6.2 12.5 1.7 7.3 6.3 2.5 0.2 15.5 0.4 0.1 1.7 0.1 0.2 1.8 1.1 2.2 73.2 0.5 0.8 0.3 0.4 0.3 0.2 1.2 0.3 0.9 0.5 0.3 0.8 1.5 0.9 0.5 0.2 1.1 1.7 2.0 1.8 1.3 0.3 1.7 0.5 0.8 0.4 0.7 0.2 0.5 0.1 1.5 0.2 0.1 0.2 0.5 1.2 1.6 1.2 0.1 3.9 0.6 1.5 0.4 0.6 0.6 0.7 1.7 1.8 0.9 1.1 0.5 0.8 1.8 0.1 0.7 0.4 0.8 0.6 2.8 1.5 1.2 1.7 1.4 0.5 4.1 0.4 15.5 1.1 0.1 0.6 1.7 1.0 0.3 0.2 2.5 1.7 0.9 0.6 0.1 0.2 0.2 0.6 0.1 4.3 4.0 3.3 3.5 4.5 2.0 6.4 2.7 3.7 4.9 6.0 0.6 0.0 2.5 2.1 1.3 29.0 28.1 1.4 2.3 22.7 0.0 0.4 1.7 1.0 27.5 7.1 12.9 0.0 3.6 0.4 5.4 1.4 1.1 159.9 1.6 22.3 9.8 31.3 8.6 31.3 27.0 2.2 5.0 1.0 8.8 7.5 3.5 7.0 47.4 6.5 4.7 6.5 7.6 2.7 2.5 1.4 0.1 0.0 9.7 0.7 ADH1A ADH1 ENSG00000187758 "Alcohol dehydrogenase 1A (class I), alpha polypeptide" P07327 4 99276367-99291028 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 322 "liver: 250.3" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 212.0" "Cancer enriched" "Detected in some" 251 "liver cancer: 165.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 11.2" "CAB009562, HPA047814, HPA060902" Enhanced Approved "Plasma membrane,Cytosol" NA NA 12000000 "Plasma membrane, Cytosol" "CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.89e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.40e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.78e-3)" "unprognostic (4.25e-1)" "unprognostic (4.79e-3)" "unprognostic (6.21e-2)" "unprognostic (9.36e-2)" "unprognostic (3.25e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 250.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 212.0 0.0 0.0 0.0 7.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ADH1B ADH2 ENSG00000196616 "Alcohol dehydrogenase 1B (class I), beta polypeptide" P00325 4 99304964-99352760 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 253.5;liver: 466.3" "Cell type enriched" "Detected in many" 38 "Hepatocytes: 3603.2" "Cancer enriched" "Detected in many" 31 "liver cancer: 223.1" "Group enriched" "Detected in some" 5 "midbrain: 2.3;pons and medulla: 1.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "ASC diff: 394.3" "HPA047814, HPA060902" Supported Approved "Plasma membrane,Cytosol" NA NA 16000000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.13e-2)" "unprognostic (9.80e-3)" "unprognostic (6.59e-2)" "unprognostic (5.56e-2)" "unprognostic (9.49e-2)" "unprognostic (5.53e-2)" "unprognostic (1.54e-3)" "unprognostic (1.04e-2)" "unprognostic (6.51e-2)" "unprognostic (2.73e-2)" "unprognostic (7.47e-3)" "unprognostic (7.79e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (4.60e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-2)" 253.5 12.3 0.2 21.8 0.0 0.4 78.7 0.2 0.4 18.3 60.0 0.4 5.7 3.5 12.8 14.4 33.5 22.3 31.9 24.2 0.3 0.0 9.2 466.3 43.8 17.5 2.3 0.1 18.0 8.7 0.8 5.3 0.9 1.6 30.7 10.1 2.3 11.2 3.9 20.5 11.9 25.4 30.8 2.4 5.9 10.9 18.0 0.2 0.2 16.1 9.7 2.0 42.3 76.0 0.6 0.2 1.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 394.3 57.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.1 0.0 0.6 0.3 0.4 1.2 0.8 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.0 2.3 0.1 1.6 0.2 0.0 4.3 14.0 0.4 19.8 0.0 8.9 66.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.4 9.2 0.0 46.7 0.0 0.0 81.0 0.3 1.1 3603.2 0.1 0.0 0.0 93.9 77.5 0.0 51.2 1.0 27.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 43.7 0.0 0.0 11.4 0.1 12.5 0.0 0.1 ADIPOQ "ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28" ENSG00000181092 "Adiponectin, C1Q and collagen domain containing" Q15848 3 186842690-186858463 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Hormone "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 176.7;breast: 79.4" "Cell type enriched" "Detected in single" 12 "Distal tubular cells: 1.7" "Group enriched" "Detected in some" 8 "breast cancer: 6.5;pancreatic cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 670 "ASC diff: 86.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB046467, HPA051767" Uncertain "Secreted to blood" NA NA 8360000000 1000000000 "CAB046467: AB_1078104, HPA051767: AB_2681598" "unprognostic (1.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.20e-2)" "unprognostic (6.99e-3)" "unprognostic (1.87e-1)" 176.7 1.9 0.0 16.7 0.0 0.1 79.4 0.0 0.1 0.1 23.2 0.0 0.4 0.1 0.1 1.3 0.3 0.1 13.2 5.8 0.0 0.0 0.5 0.1 0.1 6.1 0.0 0.0 0.2 1.3 0.1 0.0 0.1 0.0 0.4 1.4 0.0 14.7 0.6 2.0 1.5 2.1 0.4 0.0 0.1 0.6 0.1 0.0 0.0 0.7 9.5 0.3 1.0 0.9 0.8 0.6 2.4 0.4 0.7 0.5 0.1 0.0 0.0 0.0 0.0 86.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.6 0.4 0.3 0.3 0.4 0.3 0.3 0.1 0.8 0.3 0.5 1.9 0.7 0.4 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL845331.2 ENSG00000259916 2 94588522-94604573 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "adipose tissue: 12.1" "Cell type enriched" "Detected in single" 10 "Proximal tubular cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "ASC diff: 6.8" NA NA "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (8.07e-3)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (9.15e-3)" "unprognostic (6.22e-2)" "unprognostic (4.66e-2)" 12.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AOC3 "HPAO, VAP-1, VAP1" ENSG00000131471 "Amine oxidase, copper containing 3" Q16853 17 42851184-42858130 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enriched" "Detected in some" 18 "ASC diff: 85.5" "Low region specificity" "Detected in many" "HPA000980, CAB025797" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted - unknown location" NA NA 240000000 Cytosol "Golgi apparatus" "CAB025797: , HPA000980: AB_1078170" "unprognostic (2.20e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (2.64e-1)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (4.00e-2)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (5.61e-2)" "unprognostic (1.67e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (6.98e-4)" 97.0 11.5 0.4 18.7 1.0 0.0 67.7 0.5 1.3 26.9 44.3 1.0 16.3 3.6 44.7 34.8 36.1 18.5 50.9 12.1 0.4 0.4 5.8 8.3 48.0 7.9 0.5 1.2 23.8 2.4 2.2 1.3 10.8 2.0 36.5 9.4 32.1 8.0 24.7 7.7 5.5 15.0 79.2 0.6 7.5 17.7 16.2 0.3 1.0 6.6 11.6 2.6 75.9 20.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 85.5 0.1 1.3 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.3 1.5 0.1 0.1 4.7 0.2 0.0 0.2 0.9 0.2 0.1 0.2 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.7 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.1 1.2 1.4 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.5 1.3 0.4 0.4 0.5 1.2 2.0 0.3 3.0 8.9 0.8 0.0 2.6 0.0 3.2 0.0 1.4 3.4 0.0 0.0 0.1 0.0 0.1 3.8 4.7 0.0 0.0 0.2 0.1 2.6 0.2 1.1 0.0 1.1 0.0 0.0 22.7 3.0 2.1 3.1 0.5 3.3 0.0 0.0 0.4 0.1 0.0 70.4 0.7 0.5 116.4 56.5 0.9 0.7 1.6 0.2 0.0 0.0 0.3 AQP7 "AQP7L, AQP9, AQPap" ENSG00000165269 "Aquaporin 7" O14520 9 33383179-33402682 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 81.4;Early spermatids: 99.6;Enterocytes: 64.2;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 6 "T-reg: 2.7" "Lineage enriched" "Detected in single" 15 "T-cells: 2.7" "Cell line enriched" "Detected in some" 52 "ASC diff: 79.4" NA NA "unprognostic (3.25e-2)" "unprognostic (3.81e-3)" "unprognostic (1.25e-5)" "unprognostic (7.22e-3)" "unprognostic (1.50e-1)" "unprognostic (3.32e-1)" "unprognostic (4.67e-2)" "unprognostic (3.06e-2)" "unprognostic (9.99e-2)" "unprognostic (4.65e-2)" "unprognostic (8.56e-4)" "unprognostic (1.21e-1)" "prognostic favorable (9.21e-8)" "unprognostic (2.42e-1)" "unprognostic (1.28e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" 72.7 1.2 0.6 1.3 0.8 0.0 25.6 2.4 0.9 0.6 3.9 0.6 0.6 3.9 0.6 1.1 1.2 1.2 2.3 21.5 0.6 0.0 5.3 5.9 0.6 0.6 0.6 0.6 1.0 3.0 10.2 0.6 0.9 1.2 1.2 0.8 0.8 2.7 0.6 8.8 0.9 5.7 0.6 1.0 0.6 0.3 5.5 0.6 0.8 1.0 3.0 1.6 1.7 0.6 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.5 0.0 0.0 79.4 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.6 0.8 2.4 0.9 0.6 0.0 0.6 0.6 1.2 0.6 6.0 8.2 0.0 0.2 1.3 0.0 81.4 15.3 4.0 1.2 33.2 0.0 0.0 5.0 1.1 99.6 0.8 64.2 0.0 0.2 0.3 0.2 0.4 0.0 16.8 0.1 0.0 0.0 1.8 0.0 14.4 2.0 0.1 0.0 0.0 3.8 0.0 0.3 28.1 1.8 60.8 0.0 6.5 2.1 1.1 0.7 2.3 0.0 0.0 2.1 1.4 C14orf180 "C14orf77, NRAC" ENSG00000184601 "Chromosome 14 open reading frame 180" Q8N912 14 104579684-104590515 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;heart muscle: 55.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 2.6;Cardiomyocytes: 6.1;Horizontal cells: 3.2;Ito cells: 3.1" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Region enriched" "Detected in single" 11 "pons and medulla: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "ASC diff: 8.4" NA NA "unprognostic (2.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (3.19e-3)" "unprognostic (1.89e-1)" "unprognostic (3.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.32e-1)" "unprognostic (9.80e-2)" 23.2 1.2 0.0 1.7 0.2 0.1 9.8 0.0 0.1 0.5 3.8 0.7 6.7 0.3 0.3 4.7 0.2 0.4 0.7 55.1 0.0 0.3 0.7 1.9 0.2 0.3 0.0 0.0 0.3 0.7 0.1 0.6 0.7 3.9 0.4 0.2 2.0 1.7 1.2 2.5 0.1 0.5 0.5 0.0 0.2 0.5 0.4 0.0 0.0 0.2 1.3 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CD302 "BIMLEC, CLEC13A, DCL-1, KIAA0022" ENSG00000241399 "CD302 molecule" Q8IX05 2 159768630-159798255 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.8" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 257.0;Kupffer cells: 378.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 190 "dendritic cells: 17.0;granulocytes: 19.1;monocytes: 20.8" "Cell line enriched" "Detected in many" 5 "ASC diff: 77.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 16000 "unprognostic (2.52e-1)" "unprognostic (5.44e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (6.88e-2)" "unprognostic (1.68e-2)" "unprognostic (9.12e-3)" "unprognostic (5.29e-3)" "unprognostic (2.37e-2)" "unprognostic (4.38e-2)" "unprognostic (2.14e-1)" "unprognostic (4.67e-3)" "unprognostic (1.75e-2)" "unprognostic (6.61e-2)" "unprognostic (7.45e-2)" "unprognostic (3.61e-3)" 27.1 9.4 5.0 6.1 5.9 10.1 28.6 3.3 4.3 13.8 13.8 4.0 2.6 8.7 11.4 11.0 7.9 9.7 11.7 13.7 5.6 3.3 9.3 113.8 22.9 23.3 5.9 2.7 16.3 9.0 4.7 4.0 7.0 6.3 11.5 7.7 13.7 7.7 7.8 6.1 4.9 13.9 12.1 8.7 18.9 8.5 9.2 5.9 0.7 26.6 6.3 3.4 12.4 23.8 0.0 17.0 19.1 20.8 0.0 0.0 7.5 0.0 0.5 0.4 0.0 77.9 16.3 0.0 1.9 7.8 2.3 3.4 0.6 0.7 0.1 0.8 4.1 2.5 0.0 1.6 0.8 3.1 0.5 2.6 3.0 0.5 1.1 3.9 5.8 2.1 12.9 0.4 2.5 0.0 1.9 5.7 0.0 0.2 2.7 2.8 0.2 0.0 4.2 0.7 0.0 2.3 0.0 0.6 0.0 0.4 0.2 0.9 1.0 0.6 1.8 1.8 1.3 1.5 5.6 2.0 4.5 0.0 0.1 1.2 0.3 0.0 0.0 3.1 0.5 1.0 6.2 20.8 19.1 0.0 16.4 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 19.1 0.0 15.6 4.5 0.0 7.5 5.0 5.9 3.3 4.3 5.6 3.3 5.9 2.7 6.3 5.9 41.7 80.3 9.3 14.0 6.0 3.3 3.7 30.6 26.8 45.5 3.5 0.0 2.0 0.0 3.0 26.4 18.4 5.6 0.0 3.1 7.4 29.6 22.5 29.0 257.0 40.0 3.2 9.2 67.5 378.3 12.0 113.6 127.8 18.6 4.6 23.7 1.5 3.1 13.3 88.1 3.3 2.2 64.7 17.5 21.4 11.6 3.9 2.3 7.5 18.6 8.6 CIDEC "CIDE-3, FLJ20871, Fsp27" ENSG00000187288 "Cell death inducing DFFA like effector c" Q96AQ7 3 9866711-9880254 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "adipose tissue: 129.9;breast: 63.7;intestine: 60.5" "Cell type enriched" "Detected in some" 6 "Enterocytes: 107.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.2;plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "ASC diff: 197.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018837, HPA020553" Approved NA NA "HPA018837: AB_1846767, HPA020553: AB_1846769" "unprognostic (1.83e-2)" "unprognostic (3.08e-2)" "unprognostic (2.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.19e-1)" "unprognostic (7.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-5)" "unprognostic (9.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.48e-3)" "unprognostic (8.14e-2)" "unprognostic (5.37e-5)" "unprognostic (9.47e-3)" "unprognostic (2.02e-1)" "unprognostic (7.46e-3)" "unprognostic (2.94e-2)" 129.9 1.1 0.1 5.3 0.1 0.0 63.7 0.1 0.1 0.4 44.3 0.1 0.9 13.5 0.5 0.6 0.1 0.2 5.3 2.3 0.1 0.0 0.6 2.6 0.1 2.7 0.1 0.1 0.1 1.4 0.0 0.1 0.1 0.1 0.4 0.8 0.1 2.9 0.8 1.7 2.4 60.5 0.8 0.1 0.1 0.8 0.4 0.1 0.1 0.4 1.9 0.2 2.4 1.1 2.2 1.8 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 197.1 44.5 0.1 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.5 0.0 2.2 0.1 0.0 0.5 0.6 0.0 0.2 0.0 0.2 0.4 1.8 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 107.8 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.8 2.3 0.0 1.7 0.0 1.7 0.0 0.6 17.3 0.4 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.1 FHL5 "ACT, dJ393D12.2, FLJ33049" ENSG00000112214 "Four and a half LIM domains 5" Q5TD97 6 96562548-96616636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 95.7" "Group enriched" "Detected in some" 23 "Early spermatids: 1073.4;Late spermatids: 1344.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "ASC diff: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "prognostic favorable (4.81e-4)" "unprognostic (4.93e-2)" "unprognostic (1.91e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-2)" "unprognostic (6.56e-2)" "unprognostic (1.84e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.22e-1)" "unprognostic (3.48e-3)" 14.6 4.0 1.7 1.7 2.0 0.0 5.5 1.7 1.9 12.6 1.7 1.7 1.7 0.4 6.1 7.4 3.6 6.3 4.9 1.8 1.7 0.7 2.4 1.7 5.4 1.7 1.7 1.7 4.6 1.7 1.0 1.7 1.7 1.9 1.7 1.6 1.7 1.7 4.4 3.0 1.7 1.7 3.5 1.7 1.7 1.4 95.7 1.7 1.7 3.4 1.7 1.7 2.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 1.7 1.9 1.7 0.7 1.7 1.7 1.9 1.7 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1073.4 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1344.3 48.6 0.0 5.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 51.8 51.5 6.2 3.4 0.3 0.0 0.0 0.0 0.0 GPD1 ENSG00000167588 "Glycerol-3-phosphate dehydrogenase 1" P21695 12 50103819-50111319 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 116.3;skeletal muscle: 106.9" "Group enriched" "Detected in many" 5 "Hepatocytes: 94.2;Proximal tubular cells: 265.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC diff: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044620 Enhanced NA NA 3800000 "HPA044620: AB_10796803" "unprognostic (2.65e-2)" "unprognostic (5.60e-2)" "unprognostic (3.28e-2)" "unprognostic (3.37e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (1.45e-3)" "unprognostic (7.19e-2)" "unprognostic (9.42e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.37e-1)" "unprognostic (9.58e-2)" "unprognostic (3.37e-1)" "unprognostic (1.14e-1)" "unprognostic (1.12e-2)" 116.3 1.2 2.4 3.6 3.0 0.3 44.9 1.6 3.9 0.3 13.4 12.2 0.4 16.2 0.3 3.0 1.2 0.3 8.1 3.9 4.3 2.7 30.6 31.4 4.0 1.6 6.8 1.2 0.2 1.8 2.3 0.3 0.2 13.5 0.5 0.9 0.1 17.7 0.5 106.9 2.0 23.5 0.5 24.7 0.2 0.8 0.3 2.0 0.0 0.7 14.1 0.3 1.1 0.3 0.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.1 0.0 0.0 0.0 0.0 10.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 11.9 0.1 0.0 0.2 0.0 0.0 0.6 0.4 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 3.0 1.6 3.9 4.3 2.7 6.8 1.2 13.5 2.0 3.0 2.7 7.4 0.2 0.0 2.9 4.8 12.7 0.0 2.3 5.2 7.9 0.0 36.5 0.3 0.0 0.0 7.8 0.0 0.6 0.0 0.0 0.1 0.0 94.2 2.4 3.2 1.2 1.8 0.3 0.0 0.0 0.2 1.7 1.8 4.2 2.7 0.6 5.8 0.0 265.1 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.1 GPNMB "HGFIN, NMB" ENSG00000136235 "Glycoprotein nmb" Q14956 7 23235967-23275108 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 137.7" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 290.6;Hofbauer cells: 788.7;Melanocytes: 566.8;Suprabasal keratinocytes: 314.4" "Cancer enhanced" "Detected in all" "melanoma: 354.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.8;intermediate monocyte: 7.1" "Lineage enriched" "Detected in many" 6 "monocytes: 7.1" "Cell line enriched" "Detected in many" 5 "ASC diff: 329.4" "Region enhanced" "Detected in some" "olfactory region: 12.1" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA 41000000 "unprognostic (3.37e-2)" "unprognostic (1.18e-1)" "unprognostic (6.65e-2)" "unprognostic (1.82e-1)" "unprognostic (5.14e-2)" "unprognostic (4.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.89e-2)" "unprognostic (7.13e-2)" "unprognostic (2.79e-1)" "unprognostic (2.83e-1)" "unprognostic (6.40e-2)" "unprognostic (2.08e-3)" "unprognostic (1.24e-2)" "unprognostic (3.46e-2)" "unprognostic (4.82e-1)" "unprognostic (6.95e-2)" 137.7 4.3 7.7 9.5 5.9 0.7 33.8 1.0 5.5 56.0 20.7 7.9 9.2 3.5 56.5 34.6 32.6 17.3 45.8 50.0 5.5 2.8 10.8 8.9 58.7 24.1 4.4 5.0 39.7 4.0 0.3 3.7 52.7 18.2 24.8 15.7 115.7 18.1 9.8 11.3 97.2 12.1 26.2 15.7 8.4 11.2 19.8 1.5 20.6 14.0 31.7 26.7 33.4 41.9 0.4 0.8 1.2 7.1 0.3 0.2 0.8 1.1 0.0 0.0 0.0 329.4 60.0 0.0 2.1 35.7 1.7 7.6 0.0 0.0 0.0 0.0 6.8 3.2 7.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 41.3 8.6 2.9 0.3 47.8 0.0 0.0 0.0 0.0 9.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.5 27.8 0.1 0.0 0.0 11.1 51.4 0.0 0.1 0.1 0.0 10.5 1.2 19.1 0.3 0.3 0.5 0.0 3.6 0.1 10.5 0.9 3.8 0.1 0.2 7.1 0.1 0.2 0.0 0.0 0.8 0.4 0.2 0.1 1.2 0.3 0.3 0.8 0.1 0.8 7.7 5.9 1.0 5.5 5.5 2.8 4.4 5.0 18.2 1.5 17.9 28.2 2.7 6.4 290.6 0.4 176.6 2.5 2.7 14.8 71.5 0.0 5.9 3.3 0.4 2.4 9.6 0.0 0.0 0.7 2.7 76.6 1.8 20.9 3.8 788.7 1.6 0.0 6.2 136.5 2.1 120.3 119.7 566.8 4.6 0.0 0.2 0.7 0.0 101.5 0.7 0.5 0.0 64.0 3.8 1.2 314.4 24.1 0.0 0.0 10.9 GPX3 ENSG00000211445 "Glutathione peroxidase 3" P22352 5 151020438-151028993 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 844.2;thyroid gland: 424.1" "Group enriched" "Detected in many" 4 "Muller glia cells: 3198.5;Proximal tubular cells: 9534.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 856.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 16.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.7" "Cell line enriched" "Detected in some" 12 "ASC diff: 427.5" "Region enhanced" "Detected in many" "hypothalamus: 279.6" "Group enriched" "Detected in many" 4 "basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3" CAB069456 Approved "Secreted to blood" NA NA 5090000000 10000000000 "CAB069456: AB_1616682" "unprognostic (4.03e-1)" "unprognostic (7.35e-2)" "unprognostic (5.05e-3)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.13e-2)" "unprognostic (1.39e-2)" "unprognostic (1.62e-1)" "unprognostic (5.75e-3)" "unprognostic (2.70e-3)" "unprognostic (8.17e-3)" "unprognostic (1.14e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (2.14e-1)" "unprognostic (5.11e-2)" "unprognostic (1.26e-1)" 177.5 21.9 1.2 6.6 5.5 1.6 310.9 3.1 6.3 26.2 33.9 5.1 6.5 7.5 11.8 16.8 44.4 27.0 17.3 108.1 2.7 5.0 844.2 64.1 88.2 43.8 3.9 1.8 28.8 13.0 5.5 32.3 44.8 17.6 41.3 8.3 160.8 14.8 12.4 56.7 18.7 18.5 48.5 3.5 29.6 19.5 23.6 1.2 0.5 424.1 19.0 9.8 58.8 164.2 0.0 3.5 16.7 3.6 0.0 0.2 1.2 0.1 0.5 0.4 0.1 427.5 0.3 0.4 0.1 0.0 0.4 0.1 9.1 0.2 0.0 11.7 0.2 0.1 0.1 2.1 23.0 0.3 0.3 0.1 0.0 0.2 9.9 16.4 0.0 0.2 36.1 2.2 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 4.0 0.2 0.6 0.6 0.0 1.7 0.1 1.9 2.3 0.1 0.1 0.1 1.0 0.2 0.0 0.1 0.7 0.1 0.3 0.1 0.0 0.0 3.6 0.1 0.0 1.4 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 1.2 1.2 5.5 3.1 3.6 2.7 5.0 3.9 1.8 17.6 1.2 8.9 50.9 26.2 69.3 16.5 21.7 621.6 15.3 28.1 26.1 615.9 41.2 663.5 1502.1 3.9 2.4 100.8 0.7 0.0 42.8 818.8 102.8 81.4 10.5 137.7 137.1 15.9 43.8 697.9 65.5 7.5 413.6 35.5 21.9 1.0 5.6 3198.5 11.1 7.0 38.5 9534.8 68.9 672.6 191.9 3.8 10.7 18.9 1478.3 13.8 0.6 29.7 HSD11B1 "HSD11, HSD11B, SDR26C1" ENSG00000117594 "Hydroxysteroid 11-beta dehydrogenase 1" P28845 1 209686178-209734950 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 183.4" "Cell type enriched" "Detected in many" 13 "Hepatocytes: 560.1" "Cancer enriched" "Detected in all" 28 "liver cancer: 197.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 9.2" "Lineage enriched" "Detected in single" 20 "T-cells: 9.2" "Cell line enriched" "Detected in some" 5 "ASC diff: 151.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047729 Enhanced NA NA 77000 "HPA047729: AB_2680135" "unprognostic (1.08e-3)" "unprognostic (2.13e-1)" "unprognostic (2.32e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (3.63e-2)" "unprognostic (8.35e-3)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.97e-10)" "unprognostic (3.41e-2)" "unprognostic (3.91e-2)" "unprognostic (6.45e-2)" "unprognostic (1.59e-2)" 4.6 1.6 1.1 3.0 3.1 0.3 2.4 9.9 3.9 0.6 1.0 1.6 2.7 0.5 0.8 8.7 1.5 0.9 1.9 3.0 1.8 0.9 2.6 183.4 7.2 1.3 8.2 2.0 12.6 0.9 0.3 1.5 26.5 3.3 7.1 0.9 1.5 0.6 3.0 1.5 6.3 0.9 2.7 1.3 3.5 1.4 2.3 2.5 0.0 1.0 0.6 0.6 3.9 1.4 0.2 0.0 0.2 0.1 0.4 9.2 0.8 0.0 0.0 0.0 0.0 151.9 15.8 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.6 0.2 9.2 2.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 2.4 0.8 1.1 3.1 9.9 3.9 1.8 0.9 8.2 2.0 3.3 2.5 3.0 0.0 2.4 0.5 0.1 0.0 0.8 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 10.8 0.5 0.0 560.1 8.7 0.0 0.0 8.6 8.9 2.2 27.0 2.2 0.0 1.0 0.0 15.4 0.2 0.0 7.4 0.0 0.3 0.0 2.1 0.0 0.2 0.1 0.2 0.5 0.0 1.6 LIPE HSL ENSG00000079435 "Lipase E, hormone sensitive type" Q05469 19 42401507-42427426 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism" Hydrolase "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 207.4;breast: 65.1" "Group enriched" "Detected in many" 6 "Early spermatids: 123.5;Late spermatids: 188.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "ASC diff: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA006567, CAB017700" Enhanced Supported Cytosol NA NA Cytosol "CAB017700: AB_2135504, HPA006567: AB_2667618" "unprognostic (4.24e-2)" "unprognostic (2.46e-2)" "unprognostic (8.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.77e-1)" "unprognostic (3.38e-3)" "unprognostic (5.68e-2)" "unprognostic (2.84e-1)" "unprognostic (3.11e-1)" "unprognostic (9.44e-2)" "prognostic favorable (1.15e-4)" "unprognostic (1.52e-1)" "unprognostic (3.63e-10)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (3.76e-2)" "unprognostic (2.34e-3)" 207.4 6.0 3.2 2.9 9.4 2.1 65.1 2.0 6.8 1.2 6.7 19.6 0.8 2.4 1.7 1.3 2.2 1.6 3.6 4.8 6.2 4.2 1.5 1.1 1.4 2.7 18.0 2.3 1.5 2.2 2.2 0.8 1.7 9.9 1.7 1.3 3.7 5.4 1.7 3.7 2.9 3.4 1.7 19.2 3.1 1.6 9.0 10.8 1.7 1.5 1.8 1.9 2.0 3.7 6.1 4.8 10.8 12.1 4.1 5.2 4.0 4.9 3.8 2.5 0.9 57.3 0.5 0.0 2.3 1.3 3.7 3.5 0.9 1.9 8.2 2.6 0.7 1.8 2.2 1.5 4.6 0.4 1.5 2.4 2.3 1.8 0.1 1.1 0.0 5.6 0.5 4.4 0.6 0.8 0.5 1.0 3.4 1.0 5.2 0.5 0.0 5.7 0.2 0.3 3.8 1.1 4.7 0.4 2.7 1.0 5.2 3.5 3.6 2.0 2.3 2.1 0.1 0.6 3.0 1.9 1.0 3.2 0.4 2.1 3.9 3.2 6.1 2.6 0.2 3.5 10.8 12.1 4.7 3.6 6.0 3.3 4.8 4.6 5.2 4.8 6.1 4.1 3.7 2.0 4.1 3.3 3.9 3.9 4.0 3.2 9.4 2.0 6.8 6.2 4.2 18.0 2.3 9.9 10.8 0.0 3.5 1.3 10.1 3.7 8.1 2.2 0.0 0.0 0.0 1.8 9.8 0.0 1.7 6.4 123.5 4.5 3.2 23.3 2.4 0.1 1.7 5.2 0.0 0.0 0.6 7.9 0.0 17.8 1.8 188.1 2.8 1.2 5.0 0.0 1.1 3.3 1.4 0.0 1.4 1.1 12.3 0.0 1.0 26.8 12.4 2.0 0.0 6.9 2.7 9.0 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell type enriched" "Detected in many" 10 "Ito cells: 136.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "ASC diff: 60.5" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in single" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 60.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.0 0.0 7.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 0.0 5.8 0.0 0.4 1.3 0.0 4.8 5.1 0.0 0.0 14.0 0.0 0.1 0.0 0.6 8.0 14.2 0.0 0.0 0.0 0.9 3.9 0.4 0.0 1.5 0.2 0.0 0.0 136.2 6.0 7.9 9.5 0.0 0.0 9.0 0.0 0.0 0.7 0.0 3.9 2.8 0.0 0.0 0.9 0.2 0.1 0.9 0.6 0.0 0.0 0.0 OR13C2 ENSG00000276119 "Olfactory receptor family 13 subfamily C member 2" Q8NGS9 9 104604671-104605627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "ASC diff: 1.5" NA NA 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.2 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.9" "Group enriched" "Detected in many" 7 "Leydig cells: 726.0;Peritubular cells: 712.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 17 "ASC diff: 113.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052425: AB_2681826, HPA063486: AB_2685022" "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favorable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 10.6 2.4 0.5 4.2 0.7 0.0 10.9 0.6 0.5 41.7 3.1 0.5 10.2 0.0 47.9 18.9 4.6 37.6 7.3 1.9 0.5 0.0 1.3 0.5 1.3 2.0 0.8 0.5 36.3 1.4 0.6 1.0 7.7 0.7 20.9 0.8 0.5 1.4 23.7 3.5 6.7 7.4 15.3 0.8 0.5 1.3 27.0 0.6 0.8 1.8 1.8 3.0 6.7 24.1 0.0 0.0 1.0 0.0 0.0 0.6 0.6 6.3 0.9 0.0 0.8 113.9 3.6 0.9 3.5 6.7 2.8 2.8 0.6 0.8 0.0 0.6 5.3 0.1 2.5 0.5 0.9 1.4 0.3 2.6 0.1 0.6 0.3 1.8 0.1 0.1 3.5 2.0 0.4 0.3 0.1 0.0 0.9 0.7 0.0 0.1 2.8 0.5 1.1 0.0 0.5 0.5 2.7 0.3 0.2 0.2 0.5 0.2 0.0 0.3 1.5 0.0 0.0 0.8 1.4 0.0 0.4 0.0 2.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.6 0.5 0.5 0.0 0.8 0.5 0.7 0.6 0.0 0.0 0.0 4.2 12.6 0.0 0.6 0.0 0.0 2.3 0.0 0.0 11.1 0.0 0.0 5.0 0.6 1.3 0.0 0.0 96.9 87.0 2.9 0.0 0.0 8.4 0.0 0.0 0.0 0.8 6.4 726.0 1.5 15.1 0.0 1.7 0.0 0.0 0.0 712.8 0.0 0.0 32.3 19.6 3.4 4.7 8.0 20.3 0.0 1.2 0.9 PCK1 PEPCK-C ENSG00000124253 "Phosphoenolpyruvate carboxykinase 1" P35558 20 57561080-57568112 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Kinase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 419.5" "Cell type enhanced" "Detected in many" 24 "Distal tubular cells: 499.0;Enterocytes: 868.1;Hepatocytes: 756.2;Proximal tubular cells: 2559.6" "Cancer enriched" "Detected in many" 5 "liver cancer: 99.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "ASC diff: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006277, HPA006507, CAB017027" Approved NA NA 380000 "CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578" "unprognostic (3.50e-2)" "unprognostic (5.60e-2)" "unprognostic (4.60e-2)" "unprognostic (8.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.43e-2)" "unprognostic (1.84e-1)" "unprognostic (2.37e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.47e-5)" "unprognostic (1.03e-1)" "unprognostic (6.40e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-1)" 10.0 0.1 0.4 2.2 0.4 0.0 11.1 0.2 0.6 0.1 52.0 0.2 0.1 19.2 0.1 0.7 0.2 0.1 5.6 0.4 0.3 0.2 72.0 419.5 0.2 0.3 0.2 0.2 0.4 0.2 0.0 5.0 0.1 0.5 0.2 14.0 0.2 0.2 0.1 0.3 0.1 58.5 0.4 0.1 0.1 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.6 0.3 0.2 0.2 0.2 0.5 0.2 0.0 0.0 9.5 0.0 0.1 0.2 0.3 30.6 0.0 1.2 85.5 0.0 0.0 499.0 0.3 0.0 0.1 868.1 0.0 0.0 0.0 0.2 0.0 9.2 756.2 0.0 3.2 51.8 23.4 17.7 0.0 0.0 0.0 0.0 0.0 182.0 8.0 0.1 241.9 0.0 2559.6 0.2 0.0 2.1 0.0 0.0 0.3 0.2 8.5 181.4 0.0 PDK4 ENSG00000004799 "Pyruvate dehydrogenase kinase 4" Q16654 7 95583499-95596491 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 351.0;skeletal muscle: 497.0" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 766.1;Collecting duct cells: 359.4;Kupffer cells: 351.0" "Cancer enhanced" "Detected in all" "renal cancer: 107.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6" "Group enriched" "Detected in many" 11 "dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1" "Cell line enriched" "Detected in some" 7 "ASC diff: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056731 Approved NA NA "HPA056731: AB_2683218" "unprognostic (3.18e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (5.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.47e-1)" "unprognostic (6.38e-2)" "unprognostic (2.24e-3)" "unprognostic (1.87e-2)" "unprognostic (8.75e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.80e-4)" "unprognostic (9.15e-2)" "unprognostic (4.20e-2)" "unprognostic (1.12e-1)" 90.7 41.9 6.9 5.9 14.6 0.4 49.1 2.5 9.1 12.3 30.9 9.0 150.6 13.6 10.7 13.7 29.0 14.7 15.6 351.0 9.2 3.7 27.7 39.5 14.1 6.1 18.2 2.4 46.6 102.9 0.8 8.1 19.4 26.1 29.3 8.4 4.4 8.4 150.6 497.0 10.2 46.2 20.7 13.9 19.0 21.2 10.8 17.4 1.0 13.4 12.3 2.5 23.8 46.4 0.7 7.1 15.6 26.1 1.4 0.0 4.7 0.0 8.0 0.3 2.0 107.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.7 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.5 0.1 0.6 0.0 0.6 1.6 0.5 0.2 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 14.2 15.6 0.0 26.1 0.0 0.1 0.0 0.0 7.1 0.7 0.0 0.0 1.0 1.4 15.6 0.2 0.0 4.7 6.9 14.6 2.5 9.1 9.2 3.7 18.2 2.4 26.1 17.4 29.8 13.6 12.6 245.0 9.3 0.0 766.1 28.1 96.4 52.4 359.4 0.0 2.7 11.6 4.3 10.2 89.9 112.9 0.0 4.7 0.7 44.7 113.9 4.7 93.7 42.3 0.0 53.1 160.8 351.0 2.5 124.3 29.1 86.0 1.8 47.0 11.6 8.2 42.1 42.1 35.5 0.3 161.7 181.3 0.2 0.5 8.2 9.2 5.7 27.3 131.1 PLIN1 PLIN ENSG00000166819 "Perilipin 1" O60240 15 89664365-89679427 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adipose tissue: 187.5;breast: 62.6" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 49.1" "Cancer enhanced" "Detected in many" "breast cancer: 8.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 176 "ASC diff: 70.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024299, CAB033821, CAB037333" Enhanced Uncertain Peroxisomes NA NA 8900 Peroxisomes "CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467" "unprognostic (4.62e-2)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-1)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (9.89e-3)" "unprognostic (3.54e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-2)" "unprognostic (8.00e-3)" "unprognostic (2.28e-3)" "unprognostic (2.62e-6)" "unprognostic (5.56e-2)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "unprognostic (4.85e-2)" 187.5 2.6 1.8 7.1 1.3 0.3 62.6 0.8 0.8 0.3 10.6 1.6 0.4 0.4 0.3 1.9 0.5 0.4 7.4 8.3 2.7 0.6 0.6 5.8 0.3 2.8 0.8 1.5 0.4 1.4 0.3 0.1 0.3 1.0 0.4 1.1 0.0 7.6 1.5 7.2 2.2 2.2 0.6 0.4 0.3 0.5 1.6 1.8 0.0 0.7 8.0 0.3 1.5 1.5 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 70.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.8 1.3 0.8 0.7 2.7 0.6 0.8 1.5 1.0 1.8 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 49.1 0.0 0.0 0.0 1.8 1.3 4.9 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.4 0.2 0.4 0.0 0.0 0.0 0.7 PLIN4 "KIAA1881, S3-12" ENSG00000167676 "Perilipin 4" Q96Q06 19 4502180-4518465 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 31.3;Cholangiocytes: 10.2;Hepatocytes: 25.9;Ito cells: 10.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Cell line enriched" "Detected in some" 9 "ASC diff: 77.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044682, HPA054657" Enhanced Enhanced "Lipid droplets,Plasma membrane,Cytosol" NA NA 11000 "Plasma membrane, Cytosol" "Lipid droplets" "HPA044682: AB_2679044, HPA054657: AB_2682559" "unprognostic (2.97e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (8.31e-4)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.65e-2)" "unprognostic (6.77e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-2)" "unprognostic (9.89e-3)" "unprognostic (1.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (6.09e-3)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" 155.0 1.2 0.9 7.4 0.8 0.8 80.6 0.5 0.9 2.4 8.5 0.6 2.4 0.8 3.7 2.2 3.8 2.5 8.3 15.5 0.6 0.1 0.6 11.1 0.4 2.0 0.8 0.8 2.9 3.3 0.3 0.2 0.3 0.9 2.8 1.2 0.7 6.8 3.9 45.2 1.8 2.4 10.3 1.3 0.4 3.5 0.7 0.8 0.1 0.7 8.2 0.7 5.9 3.9 0.0 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 77.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.4 1.1 0.0 0.0 2.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.0 0.9 0.8 0.5 0.9 0.6 0.1 0.8 0.8 0.9 0.8 0.0 4.5 0.0 1.0 0.2 0.1 31.3 10.2 0.0 3.4 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 1.3 0.3 0.0 0.4 0.0 25.9 0.1 0.0 0.0 10.4 2.7 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.9 0.0 3.9 0.8 0.0 6.5 0.5 0.5 0.5 0.3 0.3 0.0 0.0 1.3 PRG4 "bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP" ENSG00000116690 "Proteoglycan 4" Q92954 1 186296279-186314562 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 20.9;liver: 76.0" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 298.2" "Cancer enriched" "Detected in many" 10 "liver cancer: 28.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "T-reg: 4.0" "Lineage enriched" "Detected in single" 33 "T-cells: 4.0" "Cell line enriched" "Detected in some" 7 "ASC diff: 81.7" "Low region specificity" "Detected in many" HPA028523 Uncertain "Secreted to extracellular matrix" NA NA 4300000000 "HPA028523: AB_10669642" "unprognostic (8.67e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-3)" "unprognostic (1.98e-1)" "unprognostic (1.77e-1)" "unprognostic (7.87e-2)" "unprognostic (7.33e-2)" "unprognostic (1.78e-1)" "unprognostic (1.28e-1)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (4.11e-1)" "unprognostic (1.91e-13)" "unprognostic (1.40e-2)" "unprognostic (2.60e-1)" "unprognostic (1.60e-3)" "unprognostic (7.05e-3)" 20.9 0.7 0.1 1.0 0.1 0.2 5.1 0.2 0.3 0.2 2.8 0.4 0.1 0.1 0.2 1.7 0.9 6.8 0.3 11.0 0.1 0.3 0.2 76.0 7.2 0.3 0.3 0.1 0.7 1.1 0.1 0.3 0.1 0.3 0.3 0.2 2.6 1.0 0.2 13.8 1.6 0.2 0.7 0.1 0.3 0.2 1.1 0.1 0.2 0.7 1.9 0.3 0.7 0.1 0.1 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 81.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 4.0 0.1 0.1 0.1 0.2 0.3 0.1 0.3 0.3 0.1 0.3 0.1 20.8 14.4 8.2 0.0 0.6 0.0 0.8 7.6 20.1 38.7 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 2.2 0.1 15.1 298.2 0.1 0.0 0.0 7.4 8.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.5 0.0 0.1 PROK1 "EGVEGF, PK1, PRK1" ENSG00000143125 "Prokineticin 1" P58294 1 110451200-110457354 "Predicted secreted proteins" Angiogenesis "Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ovary: 107.6;testis: 52.8" "Group enriched" "Detected in some" 50 "Leydig cells: 160.2;Peritubular cells: 627.9" "Cancer enhanced" "Detected in many" "testis cancer: 4.7" "Region enriched" "Detected in single" 9 "basal ganglia: 4.9" "Group enriched" "Detected in some" 8 "MAIT T-cell: 1.5;NK-cell: 1.0" "Group enriched" "Detected in many" 8 "NK-cells: 1.0;T-cells: 1.5" "Cell line enriched" "Detected in some" 11 "ASC diff: 23.8" "Region enriched" "Detected in single" 11 "pons and medulla: 1.4" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (2.66e-1)" "unprognostic (2.71e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" "unprognostic (3.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.24e-2)" "unprognostic (3.74e-2)" "unprognostic (7.39e-3)" "unprognostic (1.90e-1)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" 0.8 2.8 0.1 0.1 4.9 0.0 1.2 0.1 0.3 3.4 0.2 0.2 0.5 0.0 0.3 1.5 0.3 1.0 0.1 1.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 107.6 0.1 0.0 0.1 18.0 0.5 3.6 0.0 0.1 0.1 4.0 0.2 0.4 0.1 0.1 0.4 0.3 0.0 52.8 0.1 0.1 0.2 0.2 0.1 1.5 6.8 0.1 0.0 0.0 0.1 1.0 1.5 0.0 0.0 0.0 0.0 0.1 23.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 4.9 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.8 160.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 627.9 0.0 0.0 0.0 0.0 3.1 1.1 0.0 0.8 0.0 0.0 0.1 RAI2 ENSG00000131831 "Retinoic acid induced 2" Q9Y5P3 X 17800049-17861337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 45.5;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 1.5;naive CD8 T-cell: 5.1" "Lineage enriched" "Detected in single" 11 "T-cells: 5.1" "Cell line enriched" "Detected in some" 10 "ASC diff: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051054 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA051054: AB_2681328" "unprognostic (3.45e-2)" "unprognostic (9.61e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-2)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" "unprognostic (1.49e-1)" "prognostic favorable (2.77e-4)" "unprognostic (1.31e-2)" "prognostic favorable (3.39e-14)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "unprognostic (1.82e-2)" "unprognostic (2.80e-2)" 23.6 9.7 2.5 10.1 4.0 0.0 28.5 4.0 4.9 41.0 13.7 1.7 15.0 3.5 29.6 17.8 12.2 27.9 21.2 16.1 2.4 2.7 9.4 1.9 14.5 12.9 2.4 1.8 32.7 7.7 4.6 11.1 7.1 2.9 28.3 4.5 10.7 6.6 18.7 7.2 8.3 8.8 20.4 2.7 2.4 12.0 16.2 2.1 2.0 15.1 6.3 5.9 24.2 53.6 0.0 0.0 0.0 0.0 0.4 5.1 0.4 0.0 0.0 0.1 0.0 49.6 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.5 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.5 5.1 0.0 0.4 0.0 0.0 0.0 0.4 2.5 4.0 4.0 4.9 2.4 2.7 2.4 1.8 2.9 2.1 11.9 5.0 0.0 8.6 3.7 13.8 11.2 7.6 8.1 1.2 21.0 0.0 0.0 5.0 6.8 0.2 14.6 0.3 0.0 8.8 0.1 13.2 11.3 0.0 0.0 0.4 25.4 26.5 9.8 0.0 1.1 45.5 0.0 5.0 1.0 0.0 13.7 4.1 0.0 66.4 1.6 2.8 0.0 6.2 0.5 1.1 2.5 0.0 0.0 0.0 4.8 RANBP3L FLJ25422 ENSG00000164188 "RAN binding protein 3 like" Q86VV4 5 36248434-36302114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;kidney: 33.8" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 8.7;Distal tubular cells: 39.7;Muller glia cells: 12.8;Sertoli cells: 12.9" "Cancer enhanced" "Detected in some" "prostate cancer: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037471, HPA037472, HPA061526" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-3)" "unprognostic (5.52e-3)" "unprognostic (2.85e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (9.56e-2)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "unprognostic (1.28e-1)" "unprognostic (3.76e-4)" "unprognostic (1.68e-2)" "unprognostic (9.13e-2)" "unprognostic (8.87e-3)" "unprognostic (5.71e-2)" 4.6 2.8 25.7 1.0 27.5 0.8 10.7 8.5 24.5 2.4 1.1 5.6 0.6 1.0 1.4 3.1 1.4 2.3 3.0 2.5 30.3 5.6 33.8 12.2 3.2 1.1 8.2 16.5 3.4 1.2 1.1 5.3 7.0 12.2 18.6 1.3 1.0 1.5 4.7 0.9 0.9 1.0 6.6 21.4 1.0 2.7 6.4 18.4 0.0 3.6 0.0 1.5 8.2 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 16.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 27.5 8.5 21.2 30.3 5.6 8.2 16.5 12.2 18.4 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 8.7 0.0 0.0 39.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.2 0.0 1.3 1.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 1.7 0.0 0.0 12.8 0.0 0.0 2.1 0.1 0.5 12.9 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RASL11A ENSG00000122035 "RAS like family 11 member A" Q6T310 13 27270327-27273690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 18.7;Sertoli cells: 32.3;Smooth muscle cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.5" "Group enriched" "Detected in many" 5 "B-cells: 4.5;granulocytes: 3.3;monocytes: 2.9" "Cell line enriched" "Detected in many" 4 "ASC diff: 43.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004859, HPA053296" Supported Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA004859: AB_2667270, HPA053296: AB_2682106" "unprognostic (1.59e-1)" "unprognostic (9.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (6.65e-2)" "prognostic favorable (5.43e-4)" "unprognostic (3.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.65e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (3.71e-2)" "unprognostic (3.34e-1)" 18.9 5.0 2.3 8.1 9.8 3.3 36.4 5.9 5.8 11.6 15.7 7.3 4.3 13.1 14.1 10.4 9.7 14.1 6.5 9.4 4.7 2.1 17.1 30.0 11.6 26.7 3.3 1.2 13.7 3.2 1.4 7.2 5.2 3.6 15.9 20.7 8.1 6.6 10.4 4.9 6.1 24.4 28.5 3.3 17.7 8.9 8.7 5.3 0.9 7.6 3.9 16.4 16.8 27.5 4.5 0.6 3.3 2.9 0.4 0.7 0.2 0.3 1.2 0.3 0.6 43.1 4.4 0.2 1.8 1.9 0.1 0.1 7.8 0.8 0.4 0.6 1.4 1.0 0.2 2.2 0.8 0.1 1.7 8.9 1.7 0.2 0.5 7.0 0.5 0.7 4.7 0.7 0.1 0.1 1.7 0.6 0.7 0.2 0.0 0.0 0.8 0.0 2.3 1.2 7.7 10.0 0.5 0.0 0.2 1.5 5.8 0.8 0.2 0.7 3.2 0.2 1.1 0.2 0.7 0.3 0.1 0.4 2.9 0.3 0.1 0.0 0.0 0.3 1.9 0.1 1.2 2.0 0.8 0.0 0.4 0.0 0.1 0.0 0.1 0.6 4.5 0.2 0.7 3.3 0.4 2.9 0.1 0.0 0.2 2.3 9.8 5.9 5.8 4.7 2.1 3.3 1.2 3.6 5.3 14.9 9.1 0.0 2.4 4.0 0.0 1.1 0.0 18.7 14.8 7.0 0.0 0.6 3.3 1.0 0.0 1.2 6.3 0.0 2.0 0.1 1.9 1.0 0.0 0.0 1.1 0.0 0.0 1.8 0.6 0.0 0.3 3.5 1.7 1.0 5.2 0.0 0.6 11.5 1.4 1.1 0.0 32.3 45.0 0.0 0.0 3.9 0.7 0.0 6.0 0.9 SCARA5 "FLJ23907, MGC45780, NET33" ENSG00000168079 "Scavenger receptor class A member 5" Q6ZMJ2 8 27869882-27992727 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 9 "Leydig cells: 125.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 117 "plasmacytoid DC: 17.3" "Lineage enriched" "Detected in single" 173 "dendritic cells: 17.3" "Cell line enriched" "Detected in some" 20 "ASC diff: 73.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024661 Approved NA NA 1500000 "HPA024661: AB_1853902" "unprognostic (2.76e-2)" "unprognostic (7.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.53e-2)" "unprognostic (2.34e-2)" "unprognostic (4.62e-2)" "unprognostic (2.01e-1)" "unprognostic (2.15e-1)" "unprognostic (9.13e-2)" "unprognostic (2.40e-1)" "unprognostic (4.21e-2)" "unprognostic (1.10e-1)" "unprognostic (7.09e-6)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" 26.9 1.7 0.7 4.6 0.5 0.0 18.5 0.6 1.1 9.2 17.3 0.4 14.3 3.8 2.3 31.0 23.6 8.8 13.5 42.4 0.7 0.1 0.8 1.6 8.2 3.6 2.8 0.6 5.2 2.6 0.0 2.3 18.5 4.1 9.8 16.4 34.3 11.4 3.6 6.1 13.0 9.8 37.2 1.4 1.1 11.0 12.3 0.3 0.5 9.1 15.9 2.2 28.4 54.6 0.0 17.3 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 73.9 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.1 0.7 0.5 0.6 1.1 0.7 0.1 2.8 0.6 4.1 0.3 0.0 0.0 0.0 0.0 5.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 2.9 0.0 0.0 0.0 0.3 13.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 125.7 0.3 6.8 0.0 0.0 2.0 0.0 0.0 10.6 0.0 0.0 0.0 2.7 0.9 0.9 5.3 0.1 0.0 0.0 0.1 THRSP "Lpgp, LPGP1, S14, SPOT14, THRP" ENSG00000151365 "Thyroid hormone responsive" Q92748 11 78063861-78068351 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 65.3" "Cancer enhanced" "Detected in many" "liver cancer: 44.1" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Cell type enhanced" "Detected in some" "NK-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "ASC diff: 42.5" "Low region specificity" "Detected in all" HPA040642 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040642: AB_10794878" "unprognostic (1.19e-1)" "unprognostic (2.88e-1)" "unprognostic (2.84e-1)" "unprognostic (2.73e-2)" "unprognostic (3.07e-1)" "unprognostic (9.91e-3)" "unprognostic (1.59e-2)" "unprognostic (9.60e-2)" "unprognostic (1.07e-2)" "unprognostic (8.23e-2)" "unprognostic (1.68e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (9.64e-2)" "unprognostic (1.57e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.69e-3)" 62.0 1.6 0.0 18.3 0.0 0.0 22.7 1.0 0.0 0.0 12.2 0.0 2.8 0.0 0.1 1.2 0.1 0.3 16.5 11.7 0.0 0.0 2.1 92.5 0.0 2.9 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 45.6 2.0 9.3 7.2 1.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.6 4.3 0.3 5.7 0.3 0.5 0.1 0.0 0.2 1.5 1.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.5 0.1 0.5 0.2 1.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 65.3 0.0 0.0 0.0 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TUSC5 "BEC-1, IFITMD3, LOST1" ENSG00000184811 "Tumor suppressor candidate 5" Q8IXB3 17 1279663-1300987 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "adipose tissue: 79.1;breast: 63.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 268 "ASC diff: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA050825 Approved NA NA "HPA050825: AB_2681252" "unprognostic (5.84e-2)" "unprognostic (7.21e-2)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (2.91e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (1.90e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (5.10e-1)" 79.1 0.9 0.0 2.1 0.0 0.1 63.0 0.0 0.1 0.2 4.1 0.0 0.0 0.1 0.1 0.9 0.2 0.2 3.4 5.2 0.0 0.0 0.4 0.1 0.1 2.2 0.0 0.0 0.2 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 2.5 1.4 4.4 0.8 1.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.6 2.7 0.1 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0